Aayush Wellness reported a significant scale-up in financial performance for FY26, with consolidated revenue from operations more than doubling year-on-year. The company delivered strong top-line growth while maintaining profitability, reflecting successful execution of its preventive healthcare strategy.

Financial Performance

Consolidated revenue from operations stood at ₹15,548.15 lakh for the year ended March 31, 2026, up from ₹7,334.57 lakh in FY25. This represents a robust 112% year-on-year growth. Total income, which includes other income, rose to ₹15,809.17 lakh, an increase of 115% compared to the previous fiscal year.

Profitability metrics showed steady improvement alongside the revenue expansion. Profit before tax (PBT) increased to ₹440.35 lakh from ₹337.49 lakh in FY25. Net profit after tax (PAT) grew by 18% to ₹398.04 lakh, up from ₹336.58 lakh in the prior year.

Operational Highlights

The company continued to expand its integrated preventive healthcare ecosystem. Aayush Wellness launched several new nutraceutical products, including Liver Detox Tablets, Brain Fuel Capsules, and Immunity Booster Tablets. These launches targeted specific health concerns such as liver health, cognitive function, and general immunity.

The firm also strengthened its diagnostics vertical through Aayush Labs. It entered into a strategic collaboration with Healthrashi Nextgen India Limited for AI-enabled healthcare infrastructure. Additionally, the company partnered with Blinkit to enhance its omnichannel distribution network via quick commerce platforms.

Dividend and Governance

During FY26, the company paid an interim dividend of ₹0.025 per equity share. The Board of Directors proposed the reappointment of Mr. Gavadu Patil as a director and the appointment of M/s. A. Raghavendra Rao & Associates as statutory auditors for five years.

The Secretarial Audit Report noted a delay in filling the casual vacancy caused by the resignation of the previous statutory auditor, M/s. A J M S & Co. LLP. The Board appointed the new auditors in May 2026, after the prescribed 30-day period.

What the Numbers Show

The divergence between revenue growth and net profit expansion highlights the investment phase of the business. While revenue surged 112%, net profit grew only 18%. This compression in net margin—from approximately 4.6% in FY25 to 2.5% in FY26—indicates that operating expenses and marketing costs scaled faster than earnings during this period of rapid top-line expansion.

Aayush Wellness Limited published the newspaper advertisement for its 42nd Annual General Meeting (AGM) on September 5, 2026. The meeting is scheduled for September 29, 2026.

The company’s Board of Directors had previously approved the notice and proposed key governance appointments on September 3, 2026. The board meeting, held in Mumbai, focused on procedural matters for the upcoming shareholder vote. No financial results were declared during this session.

Governance Appointments

The board proposed the reappointment of Mr. Gavadu Patil as a Non-Executive Non-Independent Director. Mr. Patil retires by rotation at the ensuing AGM and has offered himself for reappointment. He brings over two decades of experience in business operations and technology.

Additionally, the company proposed appointing M/s. A. Raghavendra Rao & Associates as Statutory Auditors. The firm will serve for five consecutive years, from the conclusion of the 42nd AGM to the 47th AGM, subject to member approval.

AGM Logistics

The 42nd AGM will be conducted via Video Conferencing or Other Audio-Visual Means. Key dates for shareholders are outlined below:

M/s. Aarju Agrawal & Associates has been appointed as the Scrutinizer to ensure fair and transparent voting procedures.